Clinical Trial Update: Lapatinib Ditosylate and Radiation Therapy in Treating Patients With Locally Advanced or Locally Recurrent Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial of lapatinib with radiation therapy for locally advanced or locally recurrent breast cancer; the study was terminated with results posted on 2017-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Locally Recurrent Breast Cancer
• Male Breast Cancer

Drugs mentioned

• Lapatinib (Lapatinib)

Snippet

Sponsor: Stanford University | Conditions: Male Breast Cancer, Recurrent Breast Cancer | Phase 2 | Status: TERMINATED | Results posted: 2017-01-19